Kiromic Biopharma Inc KRBP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/26/21 EST
10.90quote price arrow down-0.01 (-0.09%)
Volume
10,525
52 week range
8.01 - 18.50

...

Loading . . .

KEY STATS

  • Open10.89
  • Day High11.07
  • Day Low10.80
  • Prev Close10.91
  • 52 Week High18.50
  • 52 Week High Date12/17/20
  • 52 Week Low8.01
  • 52 Week Low Date11/24/20
  • Market Cap79.90M
  • Shares Out7.33M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.30
  • P/E (TTM)-36.09
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kiromic Biopharma Inc News

There is no recent news for this security.

Latest KRBP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kiromic BioPharma, Inc. is a preclinical stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing immune-oncology and small molecule therapy. The Company is developing CAR cell product candidates known as ALEXIS (Allogenic Lead Exogenous Isoforms). These are designed to treat cancer and to destroy cancer cells. The Company is developing product candidates that targets for blood cancers, including large B cell lymphoma, and...
Address
7707 Fannin St., Suite 140
Houston, TX
77054
United States